FDA adds new warning to weight-loss drugs including Wegovy
The label change extends across the GLP-1 obesity class, affecting prescribers and dispensers of semaglutide products.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 1 20:52 ETSource: BusinessWorld Online
The wire
- 01The FDA has added a new warning to weight-loss drugs including Wegovy, according to the report.
- 02Label changes on semaglutide products flow through to prescribing, counseling and risk documentation for clinicians and pharmacists dispensing GLP-1s.
- 03Details of the warning's scope and wording were not laid out in the item; the FDA label itself is the authoritative source.
From the source
Read at bworldonline.comfda adds new warning to weight loss drugs including wegovy
Source URL https://bworldonline.com/page/en-DK/1842/?m
